Proteus

Overview and Classification of Proteus

  • Medical Importance: Proteus species, particularly Proteus mirabilis and Proteus vulgaris, are significant opportunistic Gram-negative pathogens. They are primary causes of severe and complicated human urinary tract infections (UTIs) and are characterized by their ability to induce the formation of mineral stones.
  • Classification: Proteus belongs to the family of Gram-negative enteric bacilli.
  • Taxonomic Distinctions:
    • Proteus: Possess >80>80 O-antigen strains and 1919 H-antigen strains. They lack K (capsular) antigens but possess fimbrial antigens (adhesins).
    • Comparison with other Enterics:
      • Escherichia: >180>180 O strains, 5353 H strains, and >80>80 K strains.
      • Salmonella: >60>60 O strains, diphasic H antigens (phases 11 and 22), and the Vi (capsular) antigen in S. typhi.
      • Shigella: 44 major serogroups; lacks H and K antigens; possesses Invasion Plasid Antigens (Ipa).
      • Klebsiella: 99 to 1212 O antigens; lacks H antigens; 7777 to 7979 K antigens (capsular polysaccharide).
      • Citrobacter: 4343 O antigens, >20>20 H antigens, and Vi antigen.

Nature and Morphological Characteristics

  • Microscopic Morphology:
    • Shape: Short, straight, rod-like bacilli.
    • Gram Stain: Gram-negative (stains pink to red due to the safranin counterstain on a thin cell wall).
    • Arrangement: Arranged as single cells or in random small structures.
  • Cell Envelope Structure:
    • Outer Membrane: Comprised of Lipopolysaccharide (LPS). The Lipid A portion serves as an endotoxin that can trigger severe inflammation and sepsis. The variable O-antigen chain is used for serotyping.
    • Periplasmic Space: Contains a thin layer of peptidoglycan that maintains the rod geometry during the "swimmer" state.
    • Inner Membrane: A symmetric phospholipid bilayer that manages metabolism and powers flagellar motors.
  • Appendages and Organelles:
    • Peritrichous Flagella: Composed of flagellin protein. In the "swarmer" state, thousands of these flagella allow bacteria to move in unified rafts across surfaces.
    • Fimbriae (Pili): Includes distinct types like MR/P (Mannose-Resistant Proteus-like) fimbriae and PMF fimbriae. These are engineered to adhere to the urinary tract lining and plastic surfaces of indwelling catheters.
    • Nucleoid and Plasmids: Features a single circular chromosome. Extrachromosomal plasmids often carry genes for multidrug resistance and specialized beta-lactamase enzymes.
    • Urease Enzyme: The cytoplasm is densely packed with active urease complexes, which define the bacterium's physiological impact by altering the surrounding chemical environment.

Cultural and Biochemical Properties

  • Cultural Properties:
    • MacConkey Agar: Produces pale, colorless, or transparent colonies (non-lactose fermenter).
    • CLED Agar: Produces isolated, blue-green colonies.
    • XLD Agar: Produces yellow or translucent colonies characterized by a black center.
    • SS Agar: Produces colorless colonies with a black center.
    • Nutrient/Blood Agar: Exhibits swarming motility, creating a wave-like film rather than isolated colonies.
  • Physiologic and Biochemical Identification:
    • Oxidase Test: Negative.
    • Catalase Test: Positive.
    • Urease Test: Positive (Rapid and intensive). Causes a pH spike that shifts indicators from pale yellow to vibrant fuchsia pink within hours.
    • Triple Sugar Iron (TSI) Slant: Alkaline/Acid (K/AK/A) with heavy H2SH_2S (hydrogen sulfide) production. The slant turns red, the butt turns yellow, and the base turns jet black.
    • Phenylalanine Deaminase (PAD) Test: Positive (indicated by a deep hunter green color on the slant).
    • Gelatin Liquefaction: Positive.
    • Methyl Red (MR): Positive.
    • Voges-Proskauer (VP): Negative.

Epidemiology and Distribution

  • Distribution in the Philippines: Proteus is a top cause of complicated UTIs and surgical site infections (SSIs) in medical and surgical wards.
  • Morbidity: It accounts for approximately 46%46\% of all nosocomial urinary tract infections when grouped with other coliforms.
  • Mortality: Urosepsis mortality rates range from 15%15\% to 30%30\%, with higher risks associated with Extended-Spectrum Beta-Lactamase (ESBL) producing strains.
  • High-Risk Populations:
    • Patients with long-term indwelling urinary catheters.
    • Individuals with structural urinary tract abnormalities.
    • Post-operative patients (specifically abdominal or bowel surgeries).

Microbiological Pathogenesis

  1. Swarming Motility and Adherence:
    • Contact with solid surfaces (catheters or bladder walls) triggers a transformation into elongated, hyper-flagellated "swarm cells."
    • Swarming allows the bacteria to travel up the urethra against the flow of urine.
    • Upon reaching a destination, the bacteria revert to short cells and utilize MR/P fimbriae to lock onto surface cells of the kidneys or bladder.
  2. Urease Production:
    • Massive quantities of urease hydrolyze urea into ammonia (NH3NH_3) and carbamate.
    • Ammonia binds to hydrogen ions to form ammonium (NH4+NH_4^+) and free hydroxyl ions (OHOH^-).
    • This reaction causes a urine pH spike from acidic (pH6.0pH \approx 6.0) to highly alkaline (pH>7.2pH > 7.2, often reaching 88 or 99).
    • Ammonia levels are toxic, chemically stripping the protective mucus layer of the bladder wall.
  3. Crystal Precipitation and Stone Formation:
    • Alkaline conditions precipitate Struvite (Magnesium ammonium phosphate: MgNH4PO46H2OMgNH_4PO_4 \cdot 6H_2O) and Carbonate Apatite (Calcium phosphate: Ca10(PO4)6CO3Ca_{10}(PO_4)_6CO_3).
    • These minerals combine with bacterial biofilms to form jagged, rapidly growing urinary stones (Staghorn calculi).
  4. The Biofilm Shield:
    • Bacteria trap mineral crystals in a sticky matrix of sugars and proteins.
    • This crystalline biofilm on catheters seals bacteria away from antibiotics and the immune system.

Host Immunologic Response

  1. Cytokine Alarm: Toll-Like Receptor 44 (TLR4) detects the O (somatic) antigen. This triggers bladder cells and macrophages to release cytokines (IL6IL-6, IL8IL-8, and TNFαTNF-\alpha). IL8IL-8 recruits neutrophils, leading to pyuria (pus/dead neutrophils in urine).
  2. Immune Evasion: Neutrophils cannot engulf large struvite stones. The stones physically irritate the tissue, causing chronic inflammation, tissue damage, and hematuria (blood in urine).
  3. Systemic Adaptive Immunity: In cases of bacteremia or pyelonephritis, B-cells produce antibodies to neutralize H (flagellar) antigens (halting movement) and the urease enzyme (blocking the active site).

Clinical Manifestations and Complications

  • Clinical Manifestations:
    • Complicated UTIs: Cystitis, dysuria, urgency, frequency, suprapubic pain, and a strong ammonia odor in urine.
    • Urinary Stones: Renal colic and persistent infection associated with staghorn calculi.
  • Complications and Emergencies:
    • Pyelonephritis: Characterized by high fever, chills, Costovertebral Angle (CVA) tenderness, nausea, and vomiting.
    • Catheter-Associated UTIs (CAUTI): Formation of thick crystalline crusts inside drainage tubes, leading to catheter blockage and potentially autonomic dysreflexia.
    • Extraintestinal Infections: Includes wound infections (diabetic foot ulcers, pressure sores, burn wounds), bacteremia, and septic shock.

Diagnostic Procedures

  • Specimen Collection: Mid-stream clean-catch urine, catheterized urine, wound swabs (from deep ulcers), or blood culture bottles.
  • Urinalysis: Distinctive finding of alkaline pH (7.57.5 to 8.58.5 or higher), positive for nitrites and leukocyte esterase.
  • Phenomenon Identification: Culture on Blood Agar or Nutrient Agar shows unmistakable swarming motility (concentric wave-like target rings) accompanied by a strong ammonia odor.
  • Serology (Weil-Felix Test):
    • O antigens of specific non-motile Proteus strains (OX-2, OX-19, and OX-K) share structural components with Rickettsia.
    • Testing involves mixing patient serum with dead Proteus OX suspensions.
    • Positive clumping indicates Rickettsial infections (e.g., Typhus or Rocky Mountain Spotted Fever).
  • Advanced Assays: VITEK 2, MicroScan, and MALDI-TOF Mass Spectrometry.

Management and Prevention

  • Targeted Antimicrobial Therapy:
    • First-line: Ampicillin, Cephalexin, or Ciprofloxacin.
    • ESBL Strains: Carbapenems or Piperacillin-Tazobactam.
  • Surgical Intervention: Necessary for stone eradication via Percutaneous Nephrolithotomy (PCNL) or Extracorporeal Shock Wave Lithotripsy (ESWL).
  • Urease Inhibitors: Acetohydroxamic Acid (AHA) is used for chronic, un-resectable stones.
  • Preventive Interventions:
    • Catheter Stewardship: Maintaining continuous closed drainage.
    • Dietary Measures: Hydration and acidification of urine using ascorbic acid or proanthocyanidin.
    • Hygiene: Rigorous hospital hand hygiene and contact precautions.

Reference

  • Source: Jawetz, Melnick & Adelberg's Medical Microbiology, 28th28^{th} Edition.
  • Authors: Stefan Riedel, Stephen A. Morse, Timothy Mietzner, Steve Miller.
  • Section: Chapter 1515, pp 231231-243243.